Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
liposomal annamycin (L-ANN)
i
Other names:
L-ANN
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Moleculin
Drug class:
DNA topoisomerase inhibitor, Topoisomerase II-alpha inhibitor, Topoisomerase II-beta inhibitor
Related drugs:
‹
SNB-101 (2)
rubitecan (1)
pirarubicin (1)
CBP-1019 (0)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
SNB-101 (2)
rubitecan (1)
pirarubicin (1)
CBP-1019 (0)
E7040 (0)
EGFREDVDox (0)
SSS22 (0)
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Soft Tissue Sarcoma
No biomarker
Soft Tissue Sarcoma
L-ANN
Sensitive: B - Late Trials
L-ANN
Sensitive
:
B
L-ANN
Sensitive: B - Late Trials
L-ANN
Sensitive
:
B
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
L-ANN
Sensitive: B - Late Trials
L-ANN
Sensitive
:
B
L-ANN
Sensitive: B - Late Trials
L-ANN
Sensitive
:
B
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login